APOA5 and hypertriglyceridemia: Our study demonstrates that magnolol could efficiently reduce the postprandial plasma triglyceride level in APOA5 c.553G>T variant carrier mice and facilitate triglyceride metabolism in mild postprandial hypertriglyceridemia.